Vitamin D Reverses aPL‐induced Inflammation and LMWH‐induced sFlt‐1 Release by Human Trophoblast
- 29 July 2014
- journal article
- research article
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 73 (3) , 242-250
Abstract
Problem: Women with antiphospholipid syndrome (APS) are at increased risk of recurrent pregnancy loss (RPL) and preeclampsia. Antiphospholipid antibodies (aPL) directly alter trophoblast function. Treatment with low molecular weight heparin (LMWH) reduces the risk of RPL but not preeclampsia. Moreover, LMWH stimulates trophoblast sFlt‐1 release, an anti‐angiogenic factor associated with preeclampsia. Since vitamin D deficiency is associated with APS and preeclampsia, this study sought to determine the effect of vitamin D on trophoblast function in the setting of aPL and LMWH.Method of study: A human first trimester trophoblast cell line (HTR8) and primary trophoblast cultures were treated with or without aPL in the presence and absence of vitamin D, LMWH or both. Trophoblast secretion of inflammatory cytokines and angiogenic factors were measured by ELISA.Results: Vitamin D alone or in combination with LMWH attenuated the aPL‐induced trophoblast inflammatory response in the HTR8 cells and primary cultures. While vitamin D did not have any impact on aPL‐mediated modulation of angiogenic factors in the primary trophoblast, it significantly inhibited LMWH‐induced sFlt‐1 release.Conclusion: LMWH in combination with vitamin D may be more beneficial than single‐agent therapy by preventing aPL‐induced trophoblast inflammation and reversing LMWH‐induced sFlt‐1 secretion.Keywords
Funding Information
- American Heart Association (10GRNT3640032)
- March of Dimes Foundation (FY12-255)
This publication has 72 references indexed in Scilit:
- Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndromeEuropean Journal of Clinical Investigation, 2012
- Obstetric and vascular APS: Same autoantibodies but different diseases?Lupus, 2012
- Pathogenesis of antiphospholipid syndrome: understanding the antibodiesNature Reviews Rheumatology, 2011
- Mechanisms of Disease: antiphospholipid antibodies—from clinical association to pathologic mechanismNature Clinical Practice Rheumatology, 2008
- Pregnancies Complicated with Antiphospholipid Syndrome: The Pathogenic Mechanism of Antiphospholipid AntibodiesAnnals of the New York Academy of Sciences, 2007
- Systemic lupus erythematosusThe Lancet, 2007
- New Facet of Antiphospholipid AntibodiesAnnals of the New York Academy of Sciences, 2005
- Effect of 2-glycoprotein I null mutation on reproductive outcome and antiphospholipid antibody-mediated pregnancy pathology in miceMolecular Human Reproduction, 2004
- Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparinBJOG: An International Journal of Obstetrics & Gynaecology, 1999
- Synthesis of β2 glycoprotein 1 by the human placentaPlacenta, 1997